Allogeneic bone marrow transplantation for hypereosinophilic syndrome with advanced myelofibrosis. 1997

A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
Département d'Hématologie et Oncologie Médicale, CHU La Milétrie, Poitiers, France.

A 33-year-old man with an atypical course of hypereosinophilic syndrome including malignant hypercalcemia, osteolytic lesions and evolution into severe myelofibrosis was treated by allogeneic bone marrow transplantation after conditioning with cytoxan and total body irradiation. As the transplant was sex-mismatched, chimerism was studied by means of cytogenetic analysis and Y chromosomal DNA amplification by PCR assay. Long-term complete remission has been assessed by normalization of blood cell counts, magnetic resonance imaging and karyotypic analysis. A relapse was observed 40 months after transplantation. The patient remains alive 44 months post-BMT. This case report is compared with those reported in the literature.

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting
D017681 Hypereosinophilic Syndrome A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs. Endocarditis, Loeffler's,Idiopathic Hypereosinophilic Syndrome,Leukemia, Eosinophilic,Loeffler's Endocarditis,Endocarditis, Loeffler,Hypereosinophilic Syndrome, Idiopathic,Loeffler Endocarditis,Endocarditis, Loefflers,Eosinophilic Leukemia,Eosinophilic Leukemias,Hypereosinophilic Syndromes,Hypereosinophilic Syndromes, Idiopathic,Idiopathic Hypereosinophilic Syndromes,Leukemias, Eosinophilic,Loefflers Endocarditis,Syndrome, Hypereosinophilic,Syndrome, Idiopathic Hypereosinophilic,Syndromes, Hypereosinophilic,Syndromes, Idiopathic Hypereosinophilic
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses

Related Publications

A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
April 1995, Bone marrow transplantation,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
January 2000, Bone marrow transplantation,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
February 1996, American journal of hematology,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
December 1995, Bone marrow transplantation,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
December 1989, British journal of haematology,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
December 1992, British journal of haematology,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
January 1989, British journal of haematology,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
March 1983, JAMA,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
April 1988, American journal of hematology,
A Sadoun, and L Lacotte, and V Delwail, and E Randriamalala, and S Patri, and P Babin, and A Brizard, and F Guilhot
November 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!